Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon MRI to Evaluate Efficacy of Therapies for Idiopathic Pulmonary Fibrosis
NCT04071769Phase 2Completed
- Sponsor
- Duke University
- Start
- Aug 2020
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized xenon gas in idiopathic pulmonary fibrosis (IPF), sponsored by Duke University. Started Aug 2020; status: completed.
02
Drugs
hyperpolarized xenon gas
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT04071769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04071769.